CVS Health Corp (NYSE:CVS) shares, rose in value on Friday, April 26, with the stock price down by -0.40% to the previous day’s close as strong demand from buyers drove the stock to $67.06.
Actively observing the price movement in the recent trading, the stock is buoying the session at $67.33. The PE ratio was 10.37 over 12-month period. Referring to stock’s 52-week performance, its high was $83.25, and the low was $64.41. On the whole, CVS has fluctuated by -15.57% over the past month.
The company’s Forward Dividend Ratio is 2.54, with its dividend yield at 3.79%.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 370.82B, with a low estimate of 87.42B and a high estimate of 91.18B. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 89.2B.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CVS’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of Hold while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the PEG ratio is about 2.81, with the price of CVS currently trading nearly -6.37% and -10.03% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 25.90, while the 7-day volatility ratio is showing 1.63% which for the 30-day chart, stands at 2.06%. Furthermore, CVS Health Corp (CVS)’s beta value is 0.55, and its average true range (ATR) is 1.49.
A comparison of CVS Health Corp (CVS) with its peers suggests the former has fared considerably weaker in the market. CVS showed an intraday change of -0.40% in today’s session so far, and over the past year, it shrunk by -7.20%%.
Data on historical trading for CVS Health Corp (NYSE:CVS) indicates that the trading volumes over the past 3 months, they’ve averaged 9.45 million. According to company’s latest data on outstanding shares, there are 1.29 billion shares outstanding.
Nearly 0.19% of CVS Health Corp’s shares belong to company insiders and institutional investors own 81.98% of the company’s shares. The stock has fallen by -15.07% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CVS stock heading into the next quarter.
